Company Overview and News
Editor's note: Seeking Alpha is proud to welcome Robert Henry Whelan as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more »
AFRAF AIBEF AF RYAAY AFLYY LUV
Ryanair Holdings plc (RYAAY - Free Report) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for RYAAY broke out below the 200 Day Simple Moving Average, suggesting short-term bearishness.
LMT RYAOF RYAAY
In the past week, key airline players like SkyWest Inc. (SKYW - Free Report) , Allegiant Travel Company (ALGT - Free Report) and Ryanair Holdings plc (RYAAY - Free Report) unveiled their respective traffic numbers for June. Impressively, all the three reports showed increase in load factor (% of seats filled by passengers) as traffic growth outweighed capacity expansion.
SKYW RYAOF JBLU RYAAY UAL ALGT ALK DAL
Ryanair Holdings plc (RYAAY - Free Report) reported impressive traffic figures for June owing to low air fares. Notably, traffic increased 7% year over year to 12.6 million in the month. In fact, the passenger count in June was the highest so far (April, May and June) at Ryanair in fiscal 2019. Passenger count in April and May were 12.3 million and 12.5 million, respectively. We note that Ryanair’s fiscal year ends on Mar 31.
GATX RYAOF CSX RYAAY GMTA NSC GMT
In the past week, Southwest Airlines Co. (LUV - Free Report) received good news on the labor front. The low-cost carrier inked a provisional labor deal with the Aircraft Mechanics Fraternal Association. Notably, the association represents 2,400 of its employees involved in the aircraft mechanics workgroup.
DB BLT BHPBF HA RYAOF UAL DLPH BHP BBL BHP RYAAY ALGT BHPLF DAL
Per a Bloomberg report, Ryanair Holdings PLC (RYAAY - Free Report) will encounter its first-ever pilot strike next week in the home market of Ireland over its alleged failure to meet demands regarding new working practices. The Irish Air Line Pilots’ Association (IALPA) representing Ryanair pilots stated that a polling by the carrier’s cockpit crew members resulted in a 94 to 1 vote in favor of industrial action including strikes.
BLT BHPBF RYAOF GATX EXPD AAWW BHP BBL BHP RYAAY GMTA BHPLF GMT
Oil prices have been on the rise this year, shooting up more than 20% so far. Apart from the geopolitical tensions in the Middle East, the economic crisis in Venezuela — a major oil exporter — and OPEC’s recent plans of a lower-than-expected output raise have backed the rally in oil prices. Since fuel expenses are significant for airlines, an increase in oil prices is unfavorable for the space.
AAL RYAOF JBLU RYAAY ALGT DAL AZUL
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
VLKAF DB RYAOF RYAAY DDAIF
For all that’s going well in this country of about 83 million people — a growing economy, booming real estate market and record-low unemployment — national pride has taken some crushing hits in recent weeks. While Germans like to remind the rest of the world that they make awesome cars, play some mean soccer, elect stable governments and possess a solid bank of global repute — those accepted truths have begun unraveling.
VLKAF DB RYAOF RYAAY DDAIF
June 14 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
FOX DSITF WPPGF CCV CMCSA RYAOF WPPGY CCZ TUNG DXCPY TGTNF TUNG VLKAF CCV.CL DC RYAAY FOXA CMCSK DIS
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
as of ET